Experiment 1210630

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE

Compounds isolated

PICIBANIL

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeIP
OrganismEmpty organism
CitationFUKUI,H: REYNOLDS,CW: LENZ,B: SCHNEIDER,M: TALMADGE,JE:. (1989). MECHANISM OF IMMUNOTHERAPEUTIC ACTIVITY OF OK-432 IN THE TREATMENT OF PERITONEAL CARCINOMATOSIS.. 29(1)
Amount utilized
Compound isolated
DiseaseDOSING TWICE PER WEEK FOR 4 WEEKS.
Number1
Qualitative resultACTIVE
AnimalMOUSE
Dose expressionDOSE